$THC Cashflow Statement | Understand Stock

$THC

$259.57 -$9.38 (3.49%) Live

$THC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Deferred income tax expense (benefit)
Stock-based compensation expense
Impairment and restructuring charges, and acquisition-related costs
Litigation and investigation costs
Net losses (gains) on sales, consolidation and deconsolidation of facilities
Loss from early extinguishment of debt
Equity in earnings of unconsolidated affiliates, net of distributions received
Amortization of debt discount and debt issuance costs
Pre-tax loss (income) from discontinued operations
Net gains from the sale of investments and long-lived assets
Other items, net
Changes in cash from operating assets and liabilities:
Accounts receivable
Inventories and other current assets
Income taxes
Accounts payable, accrued expenses and other current liabilities
Other long-term liabilities
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements
Net cash used in operating activities from discontinued operations, excluding income taxes
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of property and equipment
Purchases of businesses or joint venture interests, net of cash acquired
Proceeds from sales of facilities and other assets
Proceeds from sales of facilities and other assets — discontinued operations
Proceeds from sales of marketable securities and long-term investments
Purchases of marketable securities and long-term investments
Other items, net
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Repayments of borrowings under credit facility
Proceeds from borrowings under credit facility
Repayments of borrowings
Proceeds from borrowings
Repurchases of common stock
Debt issuance costs
Distributions paid to noncontrolling interests
Proceeds from the sale of noncontrolling interests
Purchases of noncontrolling interests
Medicare advances and grants received by unconsolidated affiliates, net of recoupment
Advances from managed care payers
Repayments of advances from managed care payers
Taxes paid related to net share settlement, net of proceeds from shares issued under stock-based compensation plans
Other items, net
Net cash used in financing activities

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosures:
Interest paid, net of capitalized interest
Income tax payments, net

Comments